Methods for modulating IKKα activity

Details Methods for modulating IKKα activity Methods for modulating IKKα activity

2007-04-26

2010-11-23

McGarry, Sean (Department: 1635)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Preparing compound containing saccharide radical

C435S006120, C435S325000, C435S375000, C536S024500

Reexamination Certificate

active

07838268

ABSTRACT:
A method for modulating NF-κB dependent gene transcription in a cell comprised of modulating IKKα protein activity in the cell. The present invention also provides siRNA compositions and methods thereof for modulating NF-κB dependent gene transcription.

REFERENCES:
patent: 4745119 (1988-05-01), Krenitsky
patent: 6235513 (2001-05-01), Rothe et al.
patent: 6258579 (2001-07-01), Mercurio et al.
patent: 6395545 (2002-05-01), Monia et al.
patent: 6649637 (2003-11-01), Curiel
patent: 7235654 (2007-06-01), Li et al.
patent: 2002/0037538 (2002-03-01), Trepicchio et al.
patent: 2002/0132788 (2002-09-01), Lewis et al.
patent: 2003/0124726 (2003-07-01), De Fougerolles et al.
patent: 2003/0143540 (2003-07-01), Matsuda et al.
patent: 2003/0166243 (2003-09-01), Cope et al.
patent: 2003/0170719 (2003-09-01), Matsuda et al.
patent: 2003/0228570 (2003-12-01), Yat Wah Tom et al.
patent: 2004/0014111 (2004-01-01), Li et al.
patent: 2005/0043257 (2005-02-01), Li et al.
patent: 2006/0073120 (2006-04-01), Li et al.
patent: 2007/0128648 (2007-06-01), Li et al.
patent: 2007/0191300 (2007-08-01), Li et al.
patent: 2009/0186010 (2009-07-01), Li et al.
patent: 9901541 (1999-01-01), None
patent: WO-03099781 (2003-12-01), None
Lu et al. (2005). Deliverying siRNA in vivo for functional genomics and novel therapeutics. From RNA Interference Technology (Cambridge, Appasani, ed., pp. 303-317).
Samarsky et al. (2005). RNAi in drug development: Practical considerations. From RNA Interference Technology (Cambridge, Appasani, ed., pp. 384-395).
Downward, J. Science, medicine, and the future. RNA interference. BMJ, 2004 vol. 328:1245-1248.
Paroo et al. Challenges for RNAi in vivo. Trends in Biotechnology, 2004 vol. 22:390-394.
O'Mahony et al. Activation of the heterodimeric I kappa B kinase alpha (IKK-alpha) -IKK beta complex is directional: IKK alpha regulates IKK beta under both basal and stimualted conditions. Molecular and Cellular Biology, 2000 vol. 20:1170-1178.
Hammond et al. Post-transcriptional gene silencing by double-stranded RNA. Nature Genetics 2001, vol. 2:110-119.
Nguyen et al. (Current Opinion in Molecular Therapeutics, 2008 vol. 10(2):158-167.
Akhtar et al. (Journal of Clinical Investigation, 2007 vol. 117:3623-3632).
De Fougerolles et al. (Nature Reviews, 2007, vol. 6:443-453).
Pahl, H.L., “Activators and Target Genes of Rel/NF-kB Transcription Factors”, Oncogene, 1999, vol. 18, p. 6853-6866.
Mercurio, F., et al. “NF-kB as a Primary Regulator of the Stress Response”, Oncogene, 1999, vol. 18, p. 6163-6171.
Barkett, M., et al. “Control of Apoptosis by Rel/NF-kB Transcription Factors”, Oncogene, 1999, vol. 18, p. 6910-6924.
Karin, M., “How NF-kB is activated: The Role of the IkB Kinase (IKK) Complex”, Oncogene, 1999, vol. 18, p. 6867-6874.
Jiang, M., et al. “Selective Silencing of Viral Gene Expression in HPV-Positive Human Cervical Carcinoma Cells Treats with siRNA, a Primer of RNA Interference”, Oncogerie, 2002, vol. 21, p. 6041-6048.
Jobin, C., et al. “The IkB/NF-kB System: A Key Determinant of Mucosal Inflammation and Protection”, American Journal of Physiology, Cellular Physiology, vol. 278, p. 451-462.
Siebenlist, U., et al.; “Structure, Regulation and Function of NF-kappaB”, Annual Review of Cell Biology, Nov. 1994, vol. 10, pp. 405-455.
Baldwin, A., Jr., et al. “The NF-kB and IkB Proteins: New Discoveries and Insights”, Annual Review of Immunology, 1996, vol. 14, p. 649-681.
Ghosh, S., et al., “NF-kB and Rel Proteins: Evolutionarily Conserved Mediators of Responses”, Annual Review of Immunology, 1998, vol. 16, p. 225-260.
Li, Z. W., et al. “The IKKb Subunit of IkB Kinase (IKK) is Essential for Nuclear Factor kB Activation and Prevention of Apoptosis”, Journal of Experimental Medicine, 1999, vol. 169, No. 11, p. 1839-1845.
Li, X., et al. “IKKa, IKKb, and NEMO/IKKy Are Each Required for the NF-kB-Mediated Inflammatory Response Program”, The Journal of Biological Chemistry, 2002, vol. 277, No. 47, p. 45129-45140.
Hu, Y., et al. “Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKa Subunit of IkB Kinase”, Science, 1999, vol. 284, p. 316-320.
Anest, V., et al. “A Nucleosomal Function for IkB Kinase-a in NF-kB-dependent Gene Expression”, Nature, 2003, vol. 423, p. 659-663.
Fire, A., et al. “Potent and Specific Genetic Interference by Double-Stranded RNA in Caenorhabditis Elegans”, Nature, 1998, vol. 391, p. 806-811.
Elbashir, S. M,, et al. “Duplexes of 21-nucleotide RNAs Mediate RNA Interference in Cultured Mammalian Cells”, Nature, 2001, vol. 411, p. 494-498.
Hannon, G. J., et al. “RNA Interference”, Nature, 2002, vol. 418, p. 244-250.
Sharp, P. A., et al, “siRNA-directed Inhibition of HIV-1 Infection”, Nature Medicine, 2002, vol. 8, p. 681-687.
Irie, N., et al. “Subtype- and Species-Specific Knockdown of PKC using Short Interfering RNA”, Biochemical and Biophysical Research Communications, 2002, vol. 298, p. 738-743.
Sharp, P. A., “RNA Interference—2001”, Genes and Development, 2001, vol. 15, p. 485-490.
McManus, M.T., et al. “Small Interfering RNA-Mediated Gene Silencing in T Lymphocytes”, Journal of Immunology, 2002, vol. 169, p. 5754-5760.
Charles A. Parkos, et al. “Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome beta”; Proc. Natl. Acad. Sci. USA; vol. 85. pp. 3319-3323; 1988.
Fang Qian, et al. “The Structure of the Mouse Cathepsin B Gene and Its Putative Promoter”; DNA and Cell Biology, vol. 10, No. 3, pp. 159-168, 1991.
Mark E. Rosenberg, et al. “Clusterin: Physiologic and Pathophysiologic Considerations”; Int. J. Biochem. Cell. Biol., vol. 27, No. 7, pp. 633-645, 1995.
Yinling Hu, et al. “IKKalpha controls formation of the epidermis independently of NF-kB”; Nature, vol. 410, pp. 710-714, 2001.
Amer A. Beg, et al. “Embryonic Lethality and Liver Degeneration in Mice Lacking the RelA Component of NF-kB”; Nature; vol. 376; pp. 167-170, 1995.
Robyn Starr, et al. “A Family of Cytokine-Inducible Inhibitors of Signalling”; Nature, vol. 387, pp. 917-921, 1997.
Mary C. Dinauer, et al. “Human Neutrophil Cytochrome b Light Chain (p22-phox)” J. Clin. Invest. vol. 86, pp. 1729-1737, 1990.
John R. Silkensen, et al. “The Role of Clusterin in Tissue Injury”, Biochem. Cell. Biol. vol. 72, pp. 483-488, 1994.
Constantin Makris, et al. “Femal Mice Heterozygous for IKKy/NEMO Deficiencies Develop a Dermatopathy Similar to the Human X-Linked Disorder Incontinentia Pigmenti”, Molecular Cell, vol. 5, pp. 969-979, 2000.
Marc Schmidt-Supprian, et al. “NEMO/IKKy-Deficient Mice Model Incontinentia Pigmenti” Molecular Cell, vol. 5, pp. 981-992, 2000.
Yixue Cao, et al. “lKKalpha Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development”, Cell, vol. 107, pp. 763-775, 2001.
Vigo Heissmeyer, et al. “Shared Pathways of IkB Kinase-Induced SCF -Mediated Ubiquitination and Degradation for the NF-kB Precursor p105 and IkBalpha”, Mol. Cell. Biol. vol. 21, No. 4, pp. 1024-1035, 2001.
Mark E. Rosenberg, et al. “Apolipoprotein J/Clusterin Prevents a Progressive Glomerulopathy of Aging”, Mol. Cell. Biol., vol. 22, No. 6, pp. 1893-1902, 2002.
Tommaso Zanocco-Marani, et al. “Biological Activities and Signaling Pathways of the Granulin/Epithelin Precursor”, Cancer Research, vol. 59, pp. 5331-5340, 1999.
Minoru Tanaka, et al. “Reconstitution of the Functional Mouse Oncostatin M (OSM) Receptor: Molecular Cloning of the Mouse OSM Receptor Beta Subunit”, Blood, vol. 93, No. 3, pp. 804-815, 1999.
John C. Groskopf, et al. “Proliferin Induces Endothelial Cell Chemotaxis through a G Protein-Coupled, Mitogen

Affiliated with

Also associated with

Rating

Methods for modulating IKKα activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for modulating IKKα activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for modulating IKKα activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4200357